(Stroke. 1996;27:2230-2235.)
© 1996 American Heart Association, Inc.
Articles |
Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly Men
the Department of Chronic Diseases and Environmental Epidemiology, National Institute of Public Health and the Environment, Bilthoven (S.K., E.J.M.F., L.J.L., D.K.); Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam (S.K., L.J.L.); and Netherlands Institute for Health Sciences, Rotterdam (S.K.), Netherlands.
Background and Purpose Cerebrovascular disease and the apolipoprotein e4 (APOE*4) allele are both important risk factors for cognitive decline. We investigated the combined effect of APOE*4 and cerebrovascular disease on cognitive decline.
Methods Data are from a cohort of 353 men, aged 69 to 89 years at baseline, living in Zutphen, Netherlands. The 30-point Mini-Mental State Examination (MMSE) was used to measure cognitive decline (drop of >2 points) from 1990 to 1993 (14% of the sample). Odds ratios (OR [95% confidence interval]) for cognitive decline were adjusted for age, education, and baseline MMSE score.
Results Compared with those without APOE*4 and without a history of cerebrovascular disease, the adjusted OR was 4.7 (1.7 to 12.7) for subjects without APOE*4 but with cerebrovascular disease, 3.3 (1.6 to 6.8) for those with APOE*4 and no cerebrovascular disease, and 17.2 (2.7 to 110.0) for those with both risk factors. The risk for cerebrovascular disease and APOE*4 combined was more than expected from the separate effects. The combined risk of coronary heart disease and APOE*4 was 6.1 (1.7 to 22.3). The analysis of cardiovascular risk factors showed that the risk of cognitive decline was highest in subjects with both APOE*4 and a high cholesterol level, high fibrinogen level, normal blood pressure, or diabetes mellitus.
Conclusions Cerebrovascular disease and APOE*4 may have a synergistic effect on cognitive decline.
Key Words: apolipoproteins • cerebrovascular disorders • cognition • dementia
This article has been cited by other articles:
 |
|
 |
|
  D. S. Knopman, R. O. Roberts, Y. E. Geda, B. F. Boeve, V. S. Pankratz, R. H. Cha, E. G. Tangalos, R. J. Ivnik, and R. C. Petersen Association of Prior Stroke With Cognitive Function and Cognitive Impairment: A Population-Based Study Arch Neurol, May 1, 2009; 66(5): 614 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Launer Diabetes: Vascular or Neurodegenerative: An Epidemiologic Perspective Stroke, March 1, 2009; 40(3_suppl_1): S53 - S55. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Singh-Manoux, S. Sabia, M. Lajnef, J. E. Ferrie, H. Nabi, A. R. Britton, M. G. Marmot, and M. J. Shipley History of coronary heart disease and cognitive performance in midlife: the Whitehall II study Eur. Heart J., September 1, 2008; 29(17): 2100 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Irie, A. L. Fitzpatrick, O. L. Lopez, L. H. Kuller, R. Peila, A. B. Newman, and L. J. Launer Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE {varepsilon}4: The Cardiovascular Health Study Cognition Study Arch Neurol, January 1, 2008; 65(1): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. P. Jin, T. Ostbye, J. W. Feightner, S. Di Legge, and V. Hachinski Joint effect of stroke and APOE 4 on dementia risk: The Canadian Study of Health and Aging Neurology, January 1, 2008; 70(1): 9 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D S KNOPMAN Cerebrovascular disease and dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S121 - S127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Laurin, K. H. Masaki, L. R. White, and L. J. Launer Ankle-to-Brachial Index and Dementia: The Honolulu-Asia Aging Study Circulation, November 13, 2007; 116(20): 2269 - 2274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Rafnsson, I. J. Deary, F. B. Smith, M. C. Whiteman, and F. G. R. Fowkes Cardiovascular Diseases and Decline in Cognitive Function in an Elderly Community Population: The Edinburgh Artery Study Psychosom Med, June 1, 2007; 69(5): 425 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A Beydoun, J. S Kaufman, J. A Satia, W. Rosamond, and A. R Folsom Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1103 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. de Frias, D. Bunce, A. Wahlin, R. Adolfsson, K. Sleegers, M. Cruts, C. Van Broeckhoven, and L.-G. Nilsson Cholesterol and Triglycerides Moderate the Effect of Apolipoprotein E on Memory Functioning in Older Adults J. Gerontol. B. Psychol. Sci. Soc. Sci., March 1, 2007; 62(2): P112 - P118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Knopman Dementia and Cerebrovascular Disease Mayo Clin. Proc., February 1, 2006; 81(2): 223 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Swan, C. N. Lessov-Schlaggar, D. Carmelli, G. D. Schellenberg, and A. La Rue Apolipoprotein E {epsilon}4 and Change in Cognitive Functioning in Community-Dwelling Older Adults J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 196 - 201. [Abstract] [PDF]
|
|
|
|
|
|
D. J. Vinkers, M. L. Stek, R. C. van der Mast, A.J.M. de Craen, S. Le Cessie, J. Jolles, R. G.J. Westendorp, and J. Gussekloo Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age Neurology, July 12, 2005; 65(1): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Lane and M. R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res., May 1, 2005; 46(5): 949 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reitz, J. Luchsinger, M. -X. Tang, J. Manly, and R. Mayeux Impact of plasma lipids and time on memory performance in healthy elderly without dementia Neurology, April 26, 2005; 64(8): 1378 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Kanaya, E. Barrett-Connor, G. Gildengorin, and K. Yaffe Change in Cognitive Function by Glucose Tolerance Status in Older Adults: A 4-Year Prospective Study of the Rancho Bernardo Study Cohort Arch Intern Med, June 28, 2004; 164(12): 1327 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Qiu, B. Winblad, J. Fastbom, and L. Fratiglioni Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD Neurology, September 9, 2003; 61(5): 655 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Ferguson, I. J. Deary, J. C. Evans, S. Ellard, A. T. Hattersley, and B. M. Frier Apolipoprotein-E Influences Aspects of Intellectual Ability in Type 1 Diabetes Diabetes, January 1, 2003; 52(1): 145 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yaffe, E. Barrett-Connor, F. Lin, and D. Grady Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women Arch Neurol, March 1, 2002; 59(3): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Peila, L.R. White, H. Petrovich, K. Masaki, G.W. Ross, R.J. Havlik, L.J. Launer, and J. Poirier Joint Effect of the APOE Gene and Midlife Systolic Blood Pressure on Late-Life Cognitive Impairment: The Honolulu-Asia Aging Study Editorial Comment: The Honolulu-Asia Aging Study Stroke, December 1, 2001; 32(12): 2882 - 2889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Mortensen and P. Hogh A gender difference in the association between APOE genotype and age-related cognitive decline Neurology, July 10, 2001; 57(1): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Helbecque, C. Berr, D. Cottel, I. Fromentin-David, V. Sazdovitch, F. Ricolfi, P. Ducimetiere, C. Di Menza, and P. Amouyel VLDL receptor polymorphism, cognitive impairment, and dementia Neurology, May 8, 2001; 56(9): 1183 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Small Age-Related Memory Decline: Current Concepts and Future Directions Arch Neurol, March 1, 2001; 58(3): 360 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Guo, L. Fratiglioni, M. Viitanen, L. Lannfelt, H. Basun, J. Fastbom, and B. Winblad Apolipoprotein E Genotypes and the Incidence of Alzheimer's Disease among Persons Aged 75 Years and Older: Variation by Use of Antihypertensive Medication? Am. J. Epidemiol., February 1, 2001; 153(3): 225 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Dik, D. J. H. Deeg, L. M. Bouter, E. H. Corder, A. Kok, and C. Jonker Stroke and Apolipoprotein E {epsilon}4 Are Independent Risk Factors for Cognitive Decline : A Population-Based Study Stroke, October 1, 2000; 31(10): 2431 - 2436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hassan and H. S. Markus Genetics and ischaemic stroke Brain, September 1, 2000; 123(9): 1784 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Juva, A. Verkkoniemi, P. Viramo, T. Polvikoski, K. Kainulainen, K. Kontula, and R. Sulkava APOE {epsilon}4 does not predict mortality, cognitive decline, or dementia in the oldest old Neurology, January 25, 2000; 54(2): 412 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhu, L. Fratiglioni, Z. Guo, H. Basun, E. H. Corder, B. Winblad, and M. Viitanen Incidence of Dementia in Relation to Stroke and the Apolipoprotein E {epsilon}4 Allele in the Very Old : Findings From a Population-Based Longitudinal Study Stroke, January 1, 2000; 31(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Moroney, M.-X. Tang, L. Berglund, S. Small, C. Merchant, K. Bell, Y. Stern, and R. Mayeux Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke JAMA, July 21, 1999; 282(3): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhu, L. Fratiglioni, Z. Guo, H. Aguero-Torres, B. Winblad, and M. Viitanen Association of Stroke With Dementia, Cognitive Impairment, and Functional Disability in the Very Old : A Population-Based Study Stroke, October 1, 1998; 29(10): 2094 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Carmelli, C. DeCarli, G. E. Swan, L. M. Jack, T. Reed, P. A. Wolf, and B. L. Miller Evidence For Genetic Variance in White Matter Hyperintensity Volume in Normal Elderly Male Twins Stroke, June 1, 1998; 29(6): 1177 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Kuller, L. Shemanski, T. Manolio, M. Haan, L. Fried, N. Bryan, G. L. Burke, R. Tracy, and R. Bhadelia Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study Stroke, February 1, 1998; 29(2): 388 - 398. [Abstract] [Full Text] [PDF]
|
|